Serum uric acid as a prognostic marker for preeclampsia at a tertiary hospital in Port Harcourt, Nigeria

Authors

  • Bapakaye Ngeri Department of Obstetrics and Gynaecology, Rivers State University Teaching Hospital, 6-8 Harley Street, Old G.R.A, Port-Harcourt, Rivers State, Nigeria
  • Peter A. Awoyesuku Department of Obstetrics and Gynaecology, Rivers State University Teaching Hospital, 6-8 Harley Street, Old G.R.A, Port-Harcourt, Rivers State, Nigeria
  • Chinweowa Ohaka Department of Obstetrics and Gynaecology, Rivers State University Teaching Hospital, 6-8 Harley Street, Old G.R.A, Port-Harcourt, Rivers State, Nigeria
  • Awopola I. Jumbo Department of Obstetrics and Gynaecology, Rivers State University Teaching Hospital, 6-8 Harley Street, Old G.R.A, Port-Harcourt, Rivers State, Nigeria
  • Omieibi B. Altraide Department of Obstetrics and Gynaecology, Rivers State University Teaching Hospital, 6-8 Harley Street, Old G.R.A, Port-Harcourt, Rivers State, Nigeria
  • Simeon C. Amadi Department of Obstetrics and Gynaecology, Rivers State University Teaching Hospital, 6-8 Harley Street, Old G.R.A, Port-Harcourt, Rivers State, Nigeria
  • Ebenezer Ikhobo Niger Delta University Teaching Hospital, Okolobiri, Bayelsa State, Nigeria

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20221660

Keywords:

Preeclampsia, Serum uric acid, Prognostic marker, Adverse pregnancy outcome

Abstract

Background: Preeclampsia is a recognized cause of maternal and perinatal morbidity and mortality. Some biomarkers such as uric acid are increased in the presence of the disease. This could serve as a marker of severity and provide a basis for making management decisions. This study sought to determine the association between elevated serum uric acid and adverse pregnancy outcomes in preeclampsia.

Methods: A prospective case-control study was carried out on consenting preeclamptic (95) and normotensive (95) pregnant women in their third trimester of pregnancy. Blood samples were taken for serum uric acid estimation at recruitment and delivery. Their Socio-demographic information was collected through a structured proforma. Data were analyzed using Statistical package for social sciences (SPSS) version 23. A p<0.05 was considered statistically significant.

Results: The mean serum uric acid level was higher in the preeclamptic than in the normotensive controls (400.0±105.27 versus 256.31±67.18; p=0.001). High serum uric acid levels were associated with a higher incidence of AKI (p=0.005), birth asphyxia (p=0.002), and low birth weight (p=0.006) compared to preeclamptics with normal uric acid levels. The sensitivity of high uric acid in predicting the outcomes was 78-81% while the specificity was 48%. Serum uric acid ≥334 µmol/l was the threshold for predicting adverse outcomes.

Conclusions: Women with preeclampsia had significantly higher serum uric acid levels. Hyperuricaemia in preeclampsia was associated with a high incidence of acute kidney injury, Birth asphyxia, and low birth weight. Serum uric acid ≥334 µmol/l was the threshold for the prediction of adverse outcomes.

 

References

Waugh JJS, Smith MC. Hypertensive disorder. In: Edmond DK(ed) Dewhurst textbook of Obstetrics and Gynaecology for postgraduate, 8th ed, Wiley-Blackwell publishing ltd. 2012;101-10.

Miller DA. Hypertension in pregnancy. In: Decherney AH, Nathan L, Laufer N, Roman AS (eds). Current diagnosis and treatment, Obstetrics and Gynaecology, 11th ed. New York McGraw-Hill. 2013;454-64.

Kooffreh M, Ekott M, Ekpoudom D. The prevalence of pre-eclampsia among pregnant women in the University of Calabar Teaching Hospital, Calabar. Saudi J Health Sci. 2014;3(3):133-8.

Singh S, Ahmed E, Egondu S, Ikechukwu N. Hypertensive disorders in pregnancy among pregnant women in a Nigerian Teaching Hospital. Niger Med J. 2014;55(5):384-8.

Ahmed A, Rezai H, Broadway-Stringer S. Evidence-Based Revised View of the Pathophysiology of Preeclampsia. Adv Exp Med Biol. 2017;956:355-74.

Say L, Chou D, Gemmill A, Tunçalp O, Moller A, Daniels J, et al. Global causes maternal death: A WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323-33.

Wagnew M, Dessalegn M, Worku A, Nyagero J. Trends of preeclampsia/eclampsia and maternal and neonatal outcomes among women delivering in Addis Ababa selected government hospitals, Ethiopia: a retrospective cross-sectional study. Pan Afr Med J. 2016;25:12-7.

Kirk K, Chattopadhyay I. A systematic review of the treatment and management of pre-eclampsia and eclampsia in Nigeria. Ending Eclampsia systematic review. Washington DC: Population Council. Reprod Health. 2016;658:1-20.

Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, et al. The detection, investigation, and management of hypertension in pregnancy: a full consensus statement. Aust N Z J Obstet Gynecol. 2000;40(2):139-55.

Girsberger M, Muff C, Hösli I, Dickenmann MJ. Short term sequelae of preeclampsia: a single-centre cohort study. BMC Pregnancy and Childbirth. 2018;18:177-83.

Wang Z, Wang Z, Wang L, Qiu M, Wang Y, Hou X, et al. Hypertensive disorders during pregnancy and risk of type 2 diabetes in later life: a systematic review and meta-analysis. Endocrine. 2017;55(3):809-21.

Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387(10022):999-1011.

Von Dadelszen P, Payne B, Li J, Ansermino JM, Pipkin FB, Côté AM, et al. PIERS Study group. Prediction of adverse maternal outcomes in pre-eclampsia: Development and validation of the fullPIERS model. Lancet. 2011;377(9761):219-27.

Gomathy G. Early-onset and late-onset preeclampsia-maternal and perinatal outcomes in a rural tertiary health centre. Int J Reprod Contracept Obstet Gynecol. 2018;7(6):2266-9.

Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1-12.

Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and future cardiovascular health. A systemic Review and meta-Analysis. Circ Cardiovasc Qual and Outcomes. 2017;10(2):116-25.

Bellomo G. Serum uric acid and pre-eclampsia: An update. Expert Rev Cardiovasc Ther. 2012;10(6):701-5.

Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, et al. Uric acid, hyperuricemia, and vascular diseases. Front Bio Sci. 2012;17:656-69.

Kalaiselvi PSJ, Gayathri B, Padmanaban S. Estimation of first-trimester serum uric acid levels as a predictor of preeclampsia among singleton pregnant patients attended at a tertiary care institution. Paripex-Indian Journal of Research. 2017;6(6):42-4.

Jido TA, Yakasai IA. Preeclampsia: A review of the evidence. Ann Afr Med. 2013;12:75-85.

Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet. 2019;145(S1):1-33.

Madazli R, Yuksel MA, Imamoglu M, Tuten A, Oncul M, Aydin B, et al. Comparison of clinical and perinatal outcomes in early- and late-onset preeclampsia. Arch Gynecol Obstet. 2014;290(1):53-7.

Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn. 2008;28(1):7-10.

Yen TW, Payne B, Qu Z, Hutcheon JA, Lee T, Magee LA, et al. Using Clinical Symptoms to Predict Adverse Maternal and Perinatal outcomes in women with Preeclampsia: Data From the PIERS (Pre-eclampsia Integrated Estimate of Risk) Study. J Obstet Gynaecol Canada. 2011;33(8):803-9.

Ramos JGL, Sass N, Costa SHM. Pré-eclâmpsia., RevistaBrasileira de Ginecologia Obstetricia. Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2017;39:496-512.

Kirbas A, Ersoy AO, Daglar K, Dikici T, Biberoglu E, Kirbas O, et al. Prediction of preeclampsia by the first trimester combined test and simple complete blood count parameters. J Clin Diagnostic Res. 2015;9(11):QC20-3.

Petla LT, Chikkala R, Ratnakar KS, Kodati V, Sritharan V. Biomarkers for the management of pre-eclampsia in pregnant women. Indian J Med Res. 2013;138:60-7.

Atoe K, AdewoluOlanike F. Plasma Lactate, Serum Uric Acid, C-Reactive Protein In Women With Pre-Eclampsia In Oredo Local Government Area, Benin City, South-South Nigeria- A Pilot Study. IOSR-JDMS. 2018;17(7):24-8.

Khurshid R, Shamsi A, Fayyaz I, Zia M. Maternal serum uric acid level during pregnancy: A biomarker for preeclampsia. Pakistan J Med Health Sci. 2016;10(2):413-5.

Bainbridge SA, Roberts JM. Uric Acid as a Pathogenic Factor in Preeclampsia. Placenta. 2008;29:67-72.

Johnson RJ, Kanbay M, Kang DH, Sánchez-Lozada LG, Feig D. Uric acid: A clinically useful marker to distinguish preeclampsia from gestational hypertension. Hypertension. 2011;58:548-9.

Zhao Y, Yang X, Lu W, Liao H, Liao F. Uricase-based methods for determination of uric acid in serum. Microchim Acta. 2009;164 (12):1-6.

Meena R, Pachori P, Chaudhary S, C. Level of serum uric acid in patients with preeclampsia compared to controls and its relation to feto-maternal outcome. Int J Reprod Contracept Obstet Gynaecol. 2019;8(6):2471-4.

Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121-6.

Niraula A, Lamsal M, Majhi S, Khan SA, Basnet P. Significance of Serum Uric acid in Pregnancy-induced hypertension. J Natl Med Assoc. 2017;109(3):198-202.

Rahman M, Shad F, Smith MC. Acute Kidney Injury: A Guide to Diagnosis and Management. Am Fam Physician. 2012;86(7):631-9.

Talaulikar VS, Shehata H. Uric acid: is it time to give up routine testing in the management of pre-eclampsia? Obstet Med. 2012;5(3):119-23.

Sultana R, Ahmed S, Sultana N, Karim SF, Atia F. Association of Serum Uric Acid with Preeclampsia: A Case-Control Study. Delta Med Coll J. 2013;1(2):46-50.

Obagah L, Kasia BE, Jeremiah I, Allagoa DO, Aigere EEOS, Kotingo EL, et al. Serum uric acid: a biochemical prognostic indicator of pregnancy outcomes among pre-eclampsia patients at the federal medical centre, Yenegoa. Int J Reprod Contracept Obstet Gynecol. 2020;9(11):4344-9.

Ugwuanyi RC, Chiege IM, Agwu FE, Eleje GU, Ifediorah NM. Association between serum uric acid levels and perinatal outcome in women with preeclampsia. Obstet Gynecol Int. 2021;8:28-35.

Ryu A, Cho NJ, Kim YS, Lee EY. Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia. Medicine (Baltimore). 2019;98:18-26.

Zulfu AA. Association of hyperuricaemia with preeclampsia: Is serum uric acid a good predictor of preeclampsia? Khartoum Sudan. ejbps. 2018;5(5):48-52.

Kondareddy T, Prathap T. Uric acid as an important biomarker in hypertensive disorders in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2016;5(12):4382-4.

Asgharnia M, Mirblouk F, Kazemi S, Pourmarzi D, MahdipourKeivani M, DalilHeirati SF. Maternal serum uric acid level and maternal and neonatal complications in preeclamptic women: A cross-sectional study. Int J Reprod Biomed. 2017;15(9):583-8.

Priya AR, Jeyapriya K, Kannan NS. Accuracy of Serum uric acid in predicting complications of pre-eclampsia. Int. J Cur Res Rev. 2016;8(5):13-21.

Enaruna N, Idemudia J, Aikoriogie P. Serum lipid profile and uric acid levels in preeclampsia in University of Benin Teaching Hospital. Niger Med J. 2014;55(5):423-7.

Zangana JM, Hamadamen AI. Serum Uric Acid as a Predictor of Perinatal Outcome in Women with Pre-Eclampsia. Int J Med Res Health Sci. 2018;7(3):168-74.

Downloads

Published

2022-06-27

Issue

Section

Original Research Articles